Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Neuromodulation. 2018 Mar 4;21(4):409–416. doi: 10.1111/ner.12760

Table 3.

Stimulation Parameters and Adverse Events

Patient Number TMS Output Adjusted Adverse Events Withdrawal Reason
Pre-Pilot: 5 Days of Treatment

Pilot-1 Not noted Headache, Nausea with Vomiting
Pilot-2 Not noted Headache
Pilot-3 Not noted Headache, Nausea with Vomiting Scheduling
Pilot-4 Not noted Headache
1 Day of TMS Treatment

5 1 Session None Reported
10 1 Session None Reported
18 1 Session None Reported
19 1 Session None Reported
20 1 Session Head Pain Head Pain
21 1 Session None Reported
5 Days of TMS Treatment

1 2 Sessions None Reported
2 4 Sessions None Reported
3 2 Sessions Painful Muscle Spasms Muscle Spasms
4 3 Sessions Painful Muscle Spasms, Headache, Fatigue
6 5 Sessions None Reported
7 3 Sessions Procedural Discomfort
8 0 Sessions Headache Head Pain
9 5 Sessions EMG electrode induced pain, Mild Head Pain
11 0 Sessions Mild Head Pain
12 None Reported Availability
13 1 Session Mild Head, Neck, and Gingival Pain
14 2 Sessions Increased Pain in All Affected Limbs
15 1 Session Head and Neck Pain, Nausea (Patient predisposed due to TMD)
16 3 Sessions None Reported
17 3 Sessions Head Pain

Temporomandibular Joint Disorders

*

Adjusted outputs ~5–10% of intensity